Trials / Conditions / Amyloidosis, Hereditary, Transthyretin-Related
Amyloidosis, Hereditary, Transthyretin-Related
6 registered clinical trials studyying Amyloidosis, Hereditary, Transthyretin-Related — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM ( NCT07116473 | Eidos Therapeutics, a BridgeBio company | Phase 3 |
| Recruiting | Exercise in Hereditary ATTR (ATTRv) Amyloidosis NCT07033715 | University of Maia | N/A |
| Unknown | Analysis of the Instestinal Microbiome of Patients With Transthyretin Amyloidosis NCT05196594 | University of Sao Paulo General Hospital | — |
| Completed | ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Fa NCT02319005 | Alnylam Pharmaceuticals | Phase 3 |
| Completed | APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)- NCT01960348 | Alnylam Pharmaceuticals | Phase 3 |
| Approved For Marketing | Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) NCT02939820 | Alnylam Pharmaceuticals | — |